We investigated the effects of nesolicaftor on the modulator correction of F508del CFTR using the 16HBE gene edited (16HBEge) human bronchial epithelial cell line with the F508del CFTR mutation engineered by the Cystic Fibrosis Foundation Therapeutics Lab [24]. The gene discussed is CFTR; the disease is cystic fibrosis.